Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 65862-187

6 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 65862-187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))
Label for Ondansetron Tablets USP 4 mg film-coated tablets by Aurobindo Pharma Limited. The label includes dosage amount, storage instructions, NDC 65862-187-05, and distributor information for Aurobindo Pharma USA, Inc. The package size is 500 tablets and the product is made in India.*
FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (4 mg Blister Carton (10 x 10 Unit-dose))
Carton packaging label for Ondansetron Tablets USP 4 mg film-coated tablets by Aurobindo Pharma Limited. The label shows the product name, strength, and quantity of 100 tablets (10 blister cards each containing 10 tablets). It includes usage instructions and storage information, along with the NDC number 65862-187-10. The label features a white and green color scheme with the Aurobindo logo.*
FDA Label Image

Package Label-principal Display Panel (8 mg (500 Tablet Bottle))

Package Label-principal Display Panel (8 mg (500 Tablet Bottle))
Label for Ondansetron Tablets, USP 8 mg, film-coated tablets, supplied in a package of 500 tablets. The label includes dosage storage instructions, manufacturer Aurobindo Pharma Limited with distribution by Aurobindo Pharma USA, Inc., and specifies the product as prescription-only. It also notes the NDC code 65862-188-05 and features barcode and printing/coding zones.*
FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (8 mg Blister Carton (10 x 10 Unit-dose))
Packaging label for Ondansetron Tablets USP 8 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates the product is Rx only and contains 100 tablets (10 blister cards with 10 tablets each). The label includes the NDC 65862-188-10 and usage instructions and warnings in small print.*
FDA Label Image

Package Label-principal Display Panel (24 mg Blister Carton (1 x 1 Unit-dose))

Package Label-principal Display Panel (24 mg Blister Carton (1 x 1 Unit-dose))
Packaging label for Ondansetron Tablet USP 24 mg film-coated tablets by Aurobindo Pharma Limited. The carton displays the product name with strength prominently in orange, includes 'Rx only' designation, and shows NDC number 65862-189-11. The label includes directions for use, storage information, barcode, and manufacturer details.*
FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure diagram of Ondansetron Hydrochloride Dihydrate, showing the molecular arrangement of the active ingredient used in film-coated tablets by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.